Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors
The purpose of this study is to determine the safety and efficacy of belzutifan in combination with pembrolizumab and lenvatinib in multiple solid tumors including hepatocellular carcinoma (HCC), colorectal cancer (CRC),